• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危非肌肉浸润性膀胱癌:为及时行膀胱切除术选择合适的患者。

High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.

机构信息

Department of Urology, Vanderbilt University Medical Center, Nashville, TN.

Department of Urology, Vanderbilt University Medical Center, Nashville, TN.

出版信息

Urology. 2021 Jan;147:7-13. doi: 10.1016/j.urology.2020.05.023. Epub 2020 May 20.

DOI:10.1016/j.urology.2020.05.023
PMID:32445767
Abstract

The heterogenous nature of high-risk nonmuscle invasive bladder cancer encompasses a wide range of tumor biologies with varying recurrence and progression risks. Radical cystectomy provides excellent oncologic outcomes but is often underutilized. Timing for these patients is critical, however, to its effectiveness. Certain unfavorable tumor characteristics predict worse outcomes and may help select the most appropriate patients for more aggressive initial therapy. This manuscript aims to outline factors that predict worse outcomes in high-risk nonmuscle invasive bladder cancer and proposes which patients may benefit most from a timely radical cystectomy.

摘要

高危非肌肉浸润性膀胱癌具有异质性,涵盖了广泛的肿瘤生物学特征,其复发和进展风险也各不相同。根治性膀胱切除术可提供良好的肿瘤学结果,但往往未被充分利用。然而,对于这些患者来说,手术时机至关重要,因为这会影响其有效性。某些不利的肿瘤特征预示着更差的预后,并可能有助于选择最合适的患者进行更积极的初始治疗。本文旨在概述预测高危非肌肉浸润性膀胱癌不良预后的因素,并提出哪些患者可能从及时的根治性膀胱切除术获益最多。

相似文献

1
High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.高危非肌肉浸润性膀胱癌:为及时行膀胱切除术选择合适的患者。
Urology. 2021 Jan;147:7-13. doi: 10.1016/j.urology.2020.05.023. Epub 2020 May 20.
2
Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.非肌层浸润性膀胱癌根治性膀胱切除术的时机和结果。
Curr Opin Urol. 2013 Sep;23(5):423-8. doi: 10.1097/MOU.0b013e328363e46f.
3
Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer.外科医生评分卡可提高非肌肉浸润性膀胱癌患者经尿道膀胱肿瘤切除术的肌肉取样和复发结果。
J Urol. 2021 Mar;205(3):693-700. doi: 10.1097/JU.0000000000001372. Epub 2020 Oct 6.
4
Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer.三联疗法治疗肌层浸润性膀胱癌的手术挑战和注意事项。
Urol Oncol. 2022 Oct;40(10):442-450. doi: 10.1016/j.urolonc.2021.01.013. Epub 2021 Feb 25.
5
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis.卡介苗失败后根治性膀胱切除术的时机:结局比较和预后危险因素分析。
J Urol. 2016 Jun;195(6):1704-9. doi: 10.1016/j.juro.2016.01.087. Epub 2016 Jan 22.
6
Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?单纯腹腔镜根治性膀胱切除术对于肌层浸润性膀胱癌的治疗而言仍是一种有吸引力的解决方案吗?
Urol Int. 2010;85(3):291-5. doi: 10.1159/000310349. Epub 2010 Apr 8.
7
The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.外科医生特征对接受根治性膀胱切除术患者的肿瘤学结果的影响的重要性。
J Urol. 2014 Sep;192(3):714-9. doi: 10.1016/j.juro.2014.02.093. Epub 2014 Mar 1.
8
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.分层对经尿道膀胱肿瘤切除术治疗的原发性高危非肌肉浸润性膀胱癌患者肿瘤学结局预测的影响。
Urol Oncol. 2020 Oct;38(10):795.e9-795.e17. doi: 10.1016/j.urolonc.2020.04.023. Epub 2020 May 14.
9
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2013 年更新版。
Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
10
Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease.非肌层浸润性疾病行根治性膀胱切除术的并发症:与肌层浸润性疾病的比较。
J Urol. 2003 Jan;169(1):101-4. doi: 10.1016/S0022-5347(05)64045-1.

引用本文的文献

1
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.加拿大泌尿外科协会非肌层浸润性膀胱癌管理指南 - 全文
Can Urol Assoc J. 2021 Aug;15(8):E424-E460. doi: 10.5489/cuaj.7367.